Phase I study of BMS-214662 and paclitaxel in patients with advanced malignancies.
Phase of Trial: Phase I
Latest Information Update: 22 Apr 2010
At a glance
- Drugs BMS 214662 (Primary) ; Paclitaxel
- Indications Solid tumours
- Focus Adverse reactions
- 02 Mar 2010 Planned number of patients changed from 21 to 5 as reported by ClinicalTrials.gov.
- 02 Mar 2010 Last checked against ClinicalTrials.gov record.
- 11 Sep 2005 New trial record.